A clinical stage biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction leading to anti-cancer immune activation. Our new approach involves the direct injection into tumors of a unique product created from our DfuseRx? discovery platform.
Lead Underwriter
Freedom Capital Markets, The Benchmark Company, LLC
